CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 353 enrolled
Drug / intervention
glycopyrronium Topical Wipes +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02530294
NCT02530294Phase 3Completed
CompareCT.gov

A Phase 3, Randomized, Double-blind, Vehicle-controlled Efficacy and Safety Study of Glycopyrronium in Subjects With Axillary Hyperhidrosis

Journey Medical Corporation·interventional·Posted Aug 21, 2015·Updated Aug 25, 2021

In Brief

A Phase 3 clinical trial evaluating glycopyrronium Topical Wipes and Vehicle for Hyperhidrosis. Completed, enrolled 353 participants across 20 sites.

Detailed Summary

The study is a randomized, double-blind, vehicle controlled, parallel group study, designed to assess the efficacy and safety of glycopyrronium topical wipes, once daily, compared to vehicle in subjects with axillary hyperhidrosis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHyperhidrosis
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 21, 2015
Enrollment StartAug 1, 2015
Primary CompletionApr 1, 2016
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 10.9 years ago

Interventions

glycopyrronium Topical Wipesdrug

Topical wipes containing glycopyrronium

Vehicleother

Vehicle (placebo) topical wipes